Skip to main content
. 2004 Sep 1;5:120. doi: 10.1186/1471-2105-5-120

Table 1.

Polymorphisms used in the present study.

Gene Polymorphism D.F.a P-Valueb
TGF-β -509 C/T 2 0.6299
IL-10 -571 C/A 2 0.1074
IL-4 -590 C/T 2 0.9085
IL-4Rα 148 G/A (Val50Ile) 2 0.0155
TXA2R 924 T/C (synonym) 1 0.5603
ADRB2 265 A/G (Arg16Gly) 2 0.0541
STAT6 2964 G/A 2 0.7881
FcεRIB 811 A/G (Glu237Gly) 1 0.5382
ITK 2860 G/A 2 0.9623
CysLT2 -580 T/C 2 0.7868
CysLT2 108 C/A 1 0.0036
CysLT2 2534 A/G 2 0.5664
IL-12B 1146 C/A 2 0.1154
IKAP 2446 A/C (Ile816Leu) 2 0.7988
IKAP 3214 T/A (Cys1072Ser) 2 0.2997
IKAP 3473 C/T (Pro1158Leu) 2 0.2779
C5 1155 A/G 2 0.1056
C5 4266 G/A 2 0.0581
C3 912 G/A 2 0.5020
C3 1692 G/A 2 0.6993
C3 4896 C/T 2 0.7205
C5aR 1289 C/A 2 0.1211
C5aR 1337 C/T 1 0.2398
C3aR 1526 G/A 1 0.7366
IL-13 329 G/A (Arg110Gln) 2 0.7924

aDegree of freedom (see text). bAssociation between SNPs and CAA was evaluated as P-value, which was calculated with χ2 test.

HHS Vulnerability Disclosure